We are live on ! Find out more
CRL icon

Charles River Laboratories

261 hedge funds and large institutions have $3.28B invested in Charles River Laboratories in 2015 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 97 increasing their positions, 95 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

357% more call options, than puts

Call options by funds: $14.9M | Put options by funds: $3.26M

13% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 31

2% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 95

1% more funds holding

Funds holding: 259261 (+2)

0.41% less ownership

Funds ownership: 98.93%98.51% (-0.41%)

12% less capital invested

Capital invested by funds: $3.71B → $3.28B (-$429M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
261
Holders Change
+2
Holders Change %
+0.77%
% of All Funds
7.03%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
35
Increased
97
Reduced
95
Closed
31
Calls
$14.9M
Puts
$3.26M
Net Calls
+$11.6M
Net Calls Change
+$10.7M
Name Holding Trade Value Shares
Change
Change in
Stake
W
251
Wealthfront
California
$10K +$10.4K +140 +2,000%
DADC
252
D.A. Davidson & Co
Montana
$9K +$296 +4 +3%
FMII
253
Farmers & Merchants Investments Inc
Nebraska
$8K
Fifth Third Bancorp
254
Fifth Third Bancorp
Ohio
$6K -$26.1K -353 -80%
LNB
255
Ledyard National Bank
$6K
WCBA
256
Weaver C. Barksdale & Associates
Tennessee
$6K
GI
257
Gradient Investments
Minnesota
$5K
Manulife (Manufacturers Life Insurance)
258
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.43K +$145K +1,955 +3%
PIA
259
Piedmont Investment Advisors
North Carolina
$1.9K
N
260
Nuveen
North Carolina
$1.71K
QCG
261
Quadrant Capital Group
Ohio
$1K +$1.7K +23 New
RIM
262
RS Investment Management
California
-$12.5M -157,265 Closed
American Century Companies
263
American Century Companies
Missouri
-$6.55M -82,573 Closed
PI
264
Putnam Investments
Massachusetts
-$4.54M -57,305 Closed
SCM
265
Sandler Capital Management
New York
-$3.7M -50,000 Closed
OAM
266
Oxford Asset Management
United Kingdom
-$3.71M -46,743 Closed
CEP
267
Chicago Equity Partners
Illinois
-$3.41M -43,005 Closed
Boston Partners
268
Boston Partners
Massachusetts
-$2.96M -37,394 Closed
MPAM
269
Monarch Partners Asset Management
Massachusetts
-$2.4M -30,325 Closed
Voloridge Investment Management
270
Voloridge Investment Management
Florida
-$1.79M -22,525 Closed
PP
271
PDT Partners
New York
-$1.4M -17,704 Closed
BCM
272
BlueCrest Capital Management
Jersey
-$1.4M -17,671 Closed
NG
273
NatWest Group
United Kingdom
-$810K -10,220 Closed
GMIM
274
General Motors Investment Management
New York
-$771K -9,720 Closed
BIM
275
BRC Investment Management
Colorado
-$700K -8,829 Closed

CRL Hedge Fund Activity: Q2 2015 in Review

261 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2015, worth a combined $3.28B — down 12% from $3.71B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new CRL positions and 31 closed out — a net gain of 4 holders — while 97 added to existing stakes and 95 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $50.3M. The largest seller was Wellington Management Group, cutting an estimated $53.7M.

  • 261 institutional investors held Charles River Laboratories (CRL) as of Q2 2015, up from 259 in Q1 2015.
  • Funds reported $3.28B of Charles River Laboratories stock for Q2 2015, down 12% quarter-over-quarter.
  • 35 funds opened new Charles River Laboratories positions in Q2 2015 and 31 closed out, a net change of +4 holders.
  • The largest Charles River Laboratories buyer in Q2 2015 was First Trust Advisors, an estimated $50.3M added.
  • The largest Charles River Laboratories seller in Q2 2015 was Wellington Management Group, an estimated $53.7M sold.

Based on aggregated 13F filings for Q2 2015.